Navigation Links
Roche Diagnostics, Cedars-Sinai Medical Center Enter Strategic Alliance for Center to Operate as a Roche Molecular Center of Excellence
Date:11/21/2011

research and outstanding medical education. It ranks among the top 10 non-university hospitals in the nation for its research activities, and its human research protection program is fully accredited by the Association for the Accreditation of Human Research Protection Programs, Inc. (AAHRPP). For more information on Cedars-Sinai Medical Center, call 1-800-CEDARS1 or visit www.cedars-sinai.edu.

About Roche

Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world's largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche is also the world leader in in-vitro diagnostics, tissue-based cancer diagnostics and a pioneer in diabetes management. Roche's personalized healthcare strategy aims at providing medicines and diagnostic tools that enable tangible improvements in the health, quality of life and survival of patients. In 2010, Roche had over 80,000 employees worldwide and invested over 9 billion Swiss francs in R&D. The Group posted sales of 47.5 billion Swiss francs. Genentech, United States, is a wholly owned member of the Roche Group. Roche has a majority stake in Chugai Pharmaceutical, Japan. For more information: www.roche.com or www.roche-diagnostics.us.

COBAS is a trademark of Roche. All trademarks mentioned in this release are protected by law.

For further information, please contact:

Betsy Cox
Director, Corporate Communications
Roche Diagnostics Corporation
Indianapolis, Indiana USA
(317) 521-3911
betsy.cox@roche.com

Nicole White
Cedars-Sinai Medical Center
Los Angeles, California USA
(310) 423-5212
'/>"/>

SOURCE Roche Diagnostics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Rochester Medical Reports Fourth Quarter and Fiscal Year End Results
2. Roche Receives FDA Approval for Acute Hepatitis B Test
3. Rochester Medical Announces Fourth Quarter 2011 Earnings Conference Call Thursday, November 3, 2011
4. Halozyme Announces Positive Results from Roches Subcutaneous Herceptin Phase 3 Trial
5. The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Anadys Pharmaceuticals Inc. in Connection with the Sale of the Company to Roche Holding AG
6. Hyam Levitsky Joins Roche as Head of Cancer Immunology Experimental Medicine
7. Rochester Medical Implants Relocates to New Facility in Noblesville, IN
8. Anadys Announces Agreement To Be Acquired By Roche
9. Study Shows That Roches Investigational Drug for Alzheimers Disease Removes Amyloid Plaques From the Brain
10. Harsukh Parmar Joins Roche as Head of Translational and Experimental Medicine - Inflammation
11. Roche to Expand Coagulation Testing Portfolio, Develop New Systems for Diagnostic Laboratories in US and Canada by 2014
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2015)... WALTHAM, Mass. , July 28, 2015  Alere ... rapid diagnostics, today announced that it will release its ... 2015. The Company will host a conference call beginning ... to discuss these results and provide business updates. ... on the Investor Relations section of Alere,s website, or ...
(Date:7/28/2015)... Calif. , July 28, 2015  Cepheid ... Omni, a flexible and portable clinical molecular diagnostic ... Point of Care market.  At just 9 inches ... Omni will run the same high quality PCR-based ... Systems, enabling highly accurate clinical molecular diagnostic tests ...
(Date:7/28/2015)... July 28, 2015 Isis Pharmaceuticals, Inc. (NASDAQ: ... a live webcast on Tuesday, August 4 at 11:30 ... financial results and report on pipeline and business progress.  ... call by dialing 877-443-5662 or access the webcast at ... for a limited time at the same address. ...
Breaking Medicine Technology:Alere to Report Second Quarter 2015 Financial Results on August 4, 2015 2World's First "Go-Anywhere" Molecular Diagnostic System Unveiled at AACC 2World's First "Go-Anywhere" Molecular Diagnostic System Unveiled at AACC 3World's First "Go-Anywhere" Molecular Diagnostic System Unveiled at AACC 4Webcast Alert: Isis Pharmaceuticals' Second Quarter 2015 Financial Results Conference Call 2Webcast Alert: Isis Pharmaceuticals' Second Quarter 2015 Financial Results Conference Call 3
... Adeona Pharmaceuticals, Inc. (AMEX: AEN ), a ... reported its second quarter 2011 financial results for the period ended ... the second quarter. Updates since the beginning of ... Multiple Sclerosis (MS) ...
... Aug. 15, 2011 /PRNewswire-Asia-FirstCall/ -- Lotus Pharmaceuticals, Inc. (OTCBB: ... and seller of medicine and drugs in the People,s ... for the quarter ended June 30, 2011. Summary financial ... Quarter Financial Highlights Revenues for ...
Cached Medicine Technology:Adeona Reports Second Quarter 2011 Financial Results 2Adeona Reports Second Quarter 2011 Financial Results 3Adeona Reports Second Quarter 2011 Financial Results 4Adeona Reports Second Quarter 2011 Financial Results 5Adeona Reports Second Quarter 2011 Financial Results 6Adeona Reports Second Quarter 2011 Financial Results 7Adeona Reports Second Quarter 2011 Financial Results 8Adeona Reports Second Quarter 2011 Financial Results 9Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results 2Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results 3Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results 4Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results 5Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results 6Lotus Pharmaceuticals Announces Second Quarter Fiscal 2011 Financial Results 7
(Date:7/28/2015)... Minn. (PRWEB) , ... July 28, 2015 , ... ... company Kinetic Data announced that Schneider Electric has completed its upgrade and ... is a global organization with more than 170,000 employees in 134 countries supplying ...
(Date:7/28/2015)... , ... July 28, 2015 , ... ... targeted biologics and biologic-device combination products for the treatment of bone disorders and ... U.S. Patent No. 9,062,300 entitled "Fusion Proteins of Collagen Binding-Domain and Parathyroid Hormone". ...
(Date:7/28/2015)... NC (PRWEB) , ... July 28, 2015 , ... ... cancers are more common in shipbreaking workers than they are in the general ... Click here to read it now. , Researchers at Taiwan’s National Health ...
(Date:7/28/2015)... ... July 28, 2015 , ... Women fear developing Alzheimer's disease more than ... heart attack, and stroke are treatable, but there is little an individual can do ... take part in a clinical trial, reports the July 2015 Harvard Women's Health ...
(Date:7/28/2015)... CA (PRWEB) , ... July 28, 2015 , ... Every ... professionals or to use extreme caution when lighting fireworks in their own neighborhoods. Unfortunately, ... and discussed in a July 3, 2015 USA Today article " Eye Injuries Caused ...
Breaking Medicine News(10 mins):Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 2Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 3Health News:Schneider Electric Amps Up Its Use of Kinetic Data’s Enterprise Request Management Software 4Health News:BiologicsMD, Inc. Announces Additional US Patent Issuance Covering Company’s Pipeline of Targeted Therapies 2Health News:New Findings Suggest Mesothelioma is Not the Only Cancer Threat for Shipbreakers, According to Surviving Mesothelioma 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 2Health News:Fight Alzheimer's By Taking Part in a Clinical Trial, From the July 2015 Harvard Women's Health Watch 3Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 2Health News:Carlsbad Ophthalmologist Discusses Doubling of Fireworks Eye Injuries in Three Year Span 3
... low fat diet lowers the cholesterol level, but low fat ... low fat diets were compared in the study. The first ... low fat diet with increased portions of vegetables, legumes, and ... fat, saturated fat, protein, carbohydrate, and cholesterol content identical to ...
... a common procedure. A new research says that influenza ... a precautionary measure., ,Influenza vaccine or the flu ... is injected into the body. This may be given ... chronic problems as well as healthy people. , ...
... Atrial fibrillation predicts for severe stroke and,early death ... the commonest cardiac arrhythmia is atrial//,fibrillation. The risk ... times,more than those with normal sinus rhythm. Previously,studies ... of,patients affected by stroke. The principle underlying,this fact ...
... sleeping time may lead to glucose intolerance and// diabetes mellitus. ... are the things that may have serious health repercussions, says a ... of Internal Medicine. For 722 men and 764 women in the ... mean sleep hours was 7 hours in the night , with ...
... A chemical compound derived from the cottonseed oil had ... neck.//, ,Scientist from University of Michigan Comprehensive Cancer ... regulates the protein called Bcl-xL, which is found over-expressed ... head or neck. ,Head and neck cancers are ...
... Hormone Replacement Therapy (HRT) is a common treatment procedure for ... life. Currently HRT had been under a lot of flak// ... risks. The newest health risk of the treatment is the ... that forms in the endometrial lining of the uterus. This ...
Cached Medicine News:
Enzyme Immunoassay of von Willebrand Factor Antigenby ELISA Method, 96 tests....
Enzyme Immunoassay of Tissue Plasminogen Activator Antigen by ELISA Method, 96 tests....
Calibration plasmas for Assays of Low Molecular Weight Heparins (LMWH)using the Anti-Xa method on STA© Analyzers....
Control Plasma for Assays of Unfractionated Heparins (UH) using Anti-Xa Methodon STA© Analyzers....
Medicine Products: